Industry is the largest energy consumer in the world, but many companies are embracing electric technologies to create truly ...

That leaves the industry with the tough question of how to reflect in premiums the new understandings of the underlying risk. “It takes a lot of premium, a lot of margin, to account for this ...

Novartis' programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First ...

After your one-month free trial ends, your subscription will automatically convert to a paid subscription, and you’ll be charged the applicable subscription fee based on the subscription term and ...